Namocell Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $126M

Namocell General Information

Description

Developer of a single-cell sorting and dispensing platform intended to empower single-cell research and therapeutics development. The company's single-cell dispensers are the fastest and easiest way to identify and isolate single cells enable users to accomplish single-cell sorting and dispensing in one step while being gentle to the cells to preserve cell viability and integrity. serve researchers and scientists in a wide range of applications, including cell line development and engineering, CRISPR and iPSC cloning, single cell genomics, cell and gene therapy, antibody discovery, rare cell isolation, single cell proteomics, and synthetic biology.

Contact Information

Website
www.namocell.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 3001 Orchard Parkway
  • San Jose, CA 95134
  • United States
+1 (800)
Primary Industry
Biotechnology
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Parent Company
Bio-Techne
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 3001 Orchard Parkway
  • San Jose, CA 95134
  • United States
+1 (800)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Namocell Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 30-Jun-2022 $126M Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Secondary Transaction - Private 01-May-2022 Completed Generating Revenue
2. Debt - PPP 30-Apr-2020 $152K Completed Generating Revenue
1. Early Stage VC (Series A) 28-Jan-2017 Completed Generating Revenue
To view Namocell’s complete valuation and funding history, request access »

Namocell Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a single-cell sorting and dispensing platform intended to empower single-cell research and therapeutics dev
Biotechnology
San Jose, CA
14 As of 2024

San Diego, CA
 

Lyon, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Namocell Competitors (3)

One of Namocell’s 3 competitors is NanoCellect Biomedical, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NanoCellect Biomedical Venture Capital-Backed San Diego, CA
Cellenion Formerly Accelerator/Incubator backed Lyon, France
Cytena Formerly VC-backed Freiburg, Germany
You’re viewing 3 of 3 competitors. Get the full list »

Namocell Patents

  • 25

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Namocell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220025326-A1 Kits and method of modifying, detecting, and sorting antibody-producing cells Inactive 27-Jul-2020
EP-4189076-A1 Kits and method of modifying, detecting, and sorting antibody-producing cells Pending 27-Jul-2020
EP-4189076-A4 Kits and method of modifying, detecting, and sorting antibody-producing cells Pending 27-Jul-2020
US-20170089826-A1 Method and apparatus for bulk microparticle sorting using a microfluidic channel Active 15-Apr-2016
US-9702808-B2 Method and apparatus for bulk microparticle sorting using a microfluidic channel Active 15-Apr-2016 G01N15/1484
To view Namocell’s complete patent history, request access »

Namocell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Namocell Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Camford Capital Venture Capital Minority
DHVC Venture Capital Minority
Foothill Ventures Venture Capital Minority
Oriza Ventures Venture Capital Minority
QB3 Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Namocell FAQs

  • When was Namocell founded?

    Namocell was founded in 2014.

  • Where is Namocell headquartered?

    Namocell is headquartered in San Jose, CA.

  • What is the size of Namocell?

    Namocell has 14 total employees.

  • What industry is Namocell in?

    Namocell’s primary industry is Biotechnology.

  • Is Namocell a private or public company?

    Namocell is a Private company.

  • What is the current valuation of Namocell?

    The current valuation of Namocell is .

  • What is Namocell’s current revenue?

    The current revenue for Namocell is .

  • Who are Namocell’s investors?

    Camford Capital, DHVC, Foothill Ventures, Oriza Ventures, and QB3 are 5 of 6 investors who have invested in Namocell.

  • Who are Namocell’s competitors?

    NanoCellect Biomedical, Cellenion, and Cytena are competitors of Namocell.

  • When was Namocell acquired?

    Namocell was acquired on 30-Jun-2022.

  • Who acquired Namocell?

    Namocell was acquired by Bio-Techne.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »